Final follicular maturation by administration of GnRH agonist plus HCG versus HCG in normal responders in ART cycles: An RCT.
Maryam Eftekhar, Maryam Farid Mojtahedi, Sepideh Miraj...
https://pubmed.ncbi.nlm.nih.gov/29177244/Actively Recruiting
Led by Al-Azhar University · Updated on 2026-10-06
100
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are comparing the effects of a dual trigger versus a conventional hCG trigger for final oocyte maturation in women who respond normally to ovarian stimulation during ICSI cycles. The study aims to evaluate embryological and reproductive outcomes to better understand which method may influence the number of mature eggs and pregnancy rates. Participants are divided into two groups one receives a combination of a GnRH agonist with hCG dual trigger, and the other receives hCG alone standard trigger. Both interventions are given in the context of ICSI treatment cycles following a GnRH antagonist protocol. The study monitors outcomes such as the number of mature oocytes, fertilization rates, embryo quality, implantation rates, pregnancy outcomes, and the incidence of ovarian hyperstimulation syndrome. During the study, participants undergo oocyte retrieval and assessment shortly afterward. Researchers measure maturation status, fertilization success approximately 16-18 hours post-insemination, embryo development by days 3-5, and clinical pregnancy rates at 5-7 weeks after embryo transfer. Safety monitoring includes tracking ovarian hyperstimulation syndrome from trigger until two weeks after retrieval. The entire study runs from initial treatment until pregnancy evaluation, with participant age limited to 20 to 40 years.
CONDITIONS
Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders
A
Ahmed MM Gebreel, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Al-Azhar University
Lead Sponsor
International Islamic Center for Population Studies and Research
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Short period around oocyte retrieval
Participants receive either the dual trigger (GnRH agonist plus hCG) or the standard hCG trigger for final oocyte maturation as part of ICSI treatment.
1 visit for oocyte retrieval and assessment
Duration - Approximately 5 to 7 weeks after embryo transfer
Researchers monitor fertilization rates, embryo quality, clinical pregnancy rates, and track any ovarian hyperstimulation syndrome from trigger until two weeks after retrieval.
Regular assessments during follow-up period
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Maryam Eftekhar, Maryam Farid Mojtahedi, Sepideh Miraj...
https://pubmed.ncbi.nlm.nih.gov/29177244/Meng-Han Yan, Jing-Xian Cao, Jin-Wei Hou...
https://pubmed.ncbi.nlm.nih.gov/35418945/Fumei Gao, Yanbin Wang, Min Fu...
https://pubmed.ncbi.nlm.nih.gov/34113641/Claus Yding Andersen, Thomas Kelsey, Linn Salto Mamsen...
https://pubmed.ncbi.nlm.nih.gov/32654823/Xingyu Zhou, Pingping Guo, Xin Chen...
https://pubmed.ncbi.nlm.nih.gov/29388691/Rebecca K Chung, Abigail C Mancuso, Karen M Summers...
https://pubmed.ncbi.nlm.nih.gov/34553157/Soha Albeitawi, Ehab Abu Marar, Firas Al Reshoud...
https://pubmed.ncbi.nlm.nih.gov/34463444/Al-Azhar University
Lead Sponsor
International Islamic Center for Population Studies and Research
Collaborating Sponsor